Form D Explorer
PharmassetX Inc. · CIK 2090938

Report a data issueCitable research briefCompare issuerPrivate research collection

PharmassetX Inc.

CIK 2090938 · Corporation · Inc. DELAWARE · LOUISVILLE, Kentucky · Pharmaceuticals

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Oct 10, 2025
through May 4, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 10, 2025 · DMay 4, 2026 · DLater minus earlier
Reported offering amount$20,000,000$6,000,000$-14,000,000
Reported amount sold$50,000$100,000$50,000
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0002090938-25-000001 · Later SEC source: 0002090938-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · May 4, 2026

Reported offering amount
$6,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$100,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)